Killing Cancer Like The Common Cold. And It's Working
December 10, 2013

Nick Wilkins was diagnosed with leukemia at just four years old. After chemotherapy, radiation therapy, and a bone marrow transplant from his sister, the cancer kept coming back. Nick was now 14 years old and the Wilkins family was running out of options.
At the time, the University of Pennsylvania was conducting an experimental therapy. Unlike the previous methods which attacked the cancer cells with poison, this approach tweaks your immune system to fight off the cancer cells just as it would the common cold.

The gray cell on the left attacks the green cancer cell, which gets smaller and eventually dies. Photo: Michael Milone/UPENN
Doctor's remove the patients T-cells, reprogram them with new genes, and infuse the cells back into the patient's body. Each cell multiplies to 10,000 cells and acts as a "hunter cell" which tracks down the cancer.
It has been six months since the treatment and doctors can not find any traces of leukemia in Nick's system. This is not a proven cure, but it is a step closer. Of 59 patients, 25 are now cancer free.
"It gives us hope that this is a cure," Nick's father says. "They're really close. I think they're really onto something."
Dogs Are Forced To Wear The Things They Steal — And It’s Hilarious
This Restaurant Owner Is Bringing Back Vintage Pizza Hut Nostalgia for a Heartwarming Reason
This Company Uses Sheep Instead of Lawn Mowers and People Are Obsessed
This Stunning Family Photo Captures Six Generations of Love in One Frame
People Thought This Arby’s Had a Random Fancy Table — Then Veterans Explained Its Powerful Meaning
Rare “Deadliest Cat in Africa” Kitten Born at Texas Zoo
‘Bring Him Back’: Ice Cream Truck Owner’s Kindness Goes Viral
Massive Dog Says ‘Nope’ to Vet Appointment, Carries Tech Off
Twins Refuse to Sleep Apart in the Sweetest Bedtime Routine
School Principal Retires, Returns as a Handyman: 'I'm Contributing Meaningfully'
Deaf Woman Brought to Tears by Glasses That Let Her Read Conversations in Real Time
